Luis Rocha M. has extensive experience in the pharmaceutical industry, beginning with a role as Representante Cardiometabólico at Merck from February 1997 to October 2007. Following this, Luis served as Representante Senior Diabetes at Bristol-Myers Squibb from January 2010 to December 2013. Currently, Luis is positioned as Representante Diabetes Cardiovascular for Forxiga-Dapagliflozina at AstraZeneca, a role held since January 2014. Luis Rocha M. holds a degree in Biology Education from Universidad de Concepción, obtained between 1985 and 1991.
This person is not in the org chart
This person is not in any teams
This person is not in any offices